111 Peter Street
Suite 300
Toronto, ON M5V 2H1
Canada
416 504 0004
https://www.thecronosgroup.com
Sector(es): Healthcare
Sector: Drug Manufacturers - Specialty & Generic
Empleados a tiempo completo: 356
Nombre | Título | Paga | Ejecutado | Año de nacimiento |
---|---|---|---|---|
Mr. Michael Ryan Gorenstein J.D. | President, CEO & Chairman | 3,94M | 89,3k | 1987 |
Mr. James Holm | Chief Financial Officer | 314,31k | N/A | 1983 |
Mr. Jeffrey David Jacobson | Chief Growth Officer | 730,12k | 363k | 1986 |
Ms. Anna Shlimak | Senior Vice President of Corporate Affairs & Strategy | 530,5k | N/A | 1986 |
Mr. James Andrew McGinness III | VP, Controller & Principal Accounting Officer | N/A | N/A | 1979 |
Mr. Shayne J. Laidlaw | Director of Investor Relations & Strategy | N/A | N/A | N/A |
Mr. Terry Gregory-Joseph Doucet | General Counsel & Corporate Secretary | N/A | N/A | 1990 |
Ms. Shannon Buggy | Senior VP & Global Head of People | 438,81k | N/A | 1970 |
Mr. Arye Weigensberg | Senior VP & Head of Research and Development | N/A | N/A | 1983 |
Cronos Group Inc. operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.
El ISS Governance QualityScore de Cronos Group Inc., a día 1 de marzo de 2024, es 10. Las puntuaciones base son Auditoría: 10; Tablero: 8; Derechos de los accionistas: 6; Compensación: 10.